ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/21/2025
Back to search
Official data from USPTO
PIONEERING SOLUTIONS THAT TURN HOPE INTO REALITY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
PIONEERING SOLUTIONS THAT TURN HOPE INTO REALITY
ST13
US500000097345667Class
40, 42
Filing
97345667
Registration
7084156
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
05/22/2025
Classification
Registered
Trademark type
Word
Nice classes
40, 42
Filing date
04/04/2022
Registration date
06/20/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/20/2023
Last transaction
05/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/01/2020
First use in commerce
09/01/2020
Drawing code
4
Owner type
03
Owner location
Columbus, OH
Examiner
RITTNER, HANNO
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Andelyn Biosciences, Inc.
Representatives
Ajay A. Jagtiani Miles & Stockbridge P.C.
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Manufacturing services for others in the field of pharmaceuticalsbiopharmaceuticalshealth care products and medical products; treatment of materialspharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticalscells and gene therapy reagents
Class 42
Product development for others relating to pharmaceuticalsbiopharmaceuticalshealth care products and medical products; scientific and technological consulting services in the pharmaceutical industryresearch and design relating thereto; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research servicesproviding analytical testingbiosafety testingreporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays
Publications
History of USPTO decisions and trademark events.
18 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/14/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/14/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/14/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/14/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/20/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/20/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/28/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/20/2022
GNRT
NON-FINAL ACTION E-MAILED
12/20/2022
CNRT
NON-FINAL ACTION WRITTEN
12/20/2022
DOCK
ASSIGNED TO EXAMINER
12/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/08/2022
NWAP
NEW APPLICATION ENTERED
04/07/2022
Continuous trademark protection
Get notified about every new filing that threatens PIONEERING SOLUTIONS THAT TURN HOPE INTO REALITY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.